Who is sponsoring NCT03615703?

NCT03615703 is sponsored by Supernus Pharmaceuticals, Inc..

What condition does NCT03615703 study?

NCT03615703 studies Impulsive Aggression.

What is the status of NCT03615703?

NCT03615703 is currently COMPLETED.

Last reviewed 2019-06-10 · How we verify

Functional MRI Study in Healthy Children Engaged in Aggressive Behaviors

NCT03615703 COMPLETED

The purpose of this non-interventional study is to optimize the point subtraction aggression paradigms (PSAP) task in typically developing children (TDC).

Details

Lead sponsor	Supernus Pharmaceuticals, Inc.
Status	COMPLETED
Enrolment	17
Start date	Fri Aug 10 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Fri Mar 15 2019 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Impulsive Aggression

Countries

United States